Our study showed that cellular senescence occurred in the liver of HFD mice, and PTUPB reduced hepatocyte senescence in NAFLD mice by restoring the sEH/COX-2 metabolic homeostasis of ARA. Here, EPHX2 is linked to metabolic dysfunction-associated steatotic liver disease.